Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis

Tore Bach-Gansmo; Anders Hodt; Fredrik Hellem Schjesvold; Einar Gude; Tale Norbye Wien

doi:10.4045/tidsskr.22.0644

Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis

Tidsskr Nor Laegeforen. 2023 Jun 12;143(9). doi: 10.4045/tidsskr.22.0644. Print 2023 Jun 13.

[Article in English, Norwegian]

Authors

Tore Bach-Gansmo, Anders Hodt, Fredrik Hellem Schjesvold, Einar Gude, Tale Norbye Wien

PMID: 37341415
DOI: 10.4045/tidsskr.22.0644

No abstract available

Plain language summary

The gold standard to diagnose suspected cardiac amyloidosis is myocardial biopsy. In recent years, bone scintigraphy has partly replaced myocardial biopsy.

MeSH terms

Biopsy*
Humans
Radionuclide Imaging